Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?

Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2019.00958
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Look How Far We Have Come

2014English

Biogenerics 2007: How Far Have We Come?

Journal of Commercial Biotechnology
BiotechnologyManagement of TechnologyEconomicsEconometricsInnovation
2008English

Progress Against Cancer (1971-2011): How Far Have We Come?

Journal of Internal Medicine
Internal Medicine
2011English

Combination Therapy for Multiple Myeloma: How Far Have We Come?

Journal of Developing Drugs
2012English

Ten Years of ART in South Africa – How Far We Have Come

Southern African Journal of HIV Medicine
Infectious Diseases
2014English

Pharmacogenetics in Clinical Practice: How Far Have We Come and Where Are We Going?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

Systems Approaches to Risk Assessing Healthcare, How Far Have We Come?

Work
MedicineEnvironmentalPublic HealthRehabilitationOccupational Health
2012English

Standardisation of Synovial Tissue Infiltrate Analysis: How Far Have We Come? How Much Further Do We Need to Go?

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

Diversity of Tanaidacea (Crustacea: Peracarida) in the World's Oceans – How Far Have We Come?

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy